Acquisition of a Next Generation Orbitrap MS
Acquisition of a Next Generation Orbitrap MS
批准号:
8640367
负责人:
Michael A. Freitas
金额:
$57.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-07-15 至 2015-07-14
关键词:
CalibrationCellsData QualityDissociationFundingHybridsIonsPerformancePost Translational Modification AnalysisProcessProteinsProteomicsRequest for ApplicationsResolutionSamplingScanningSourceStagingTimeTissue Sampledata acquisitiondesignflexibilityhuman tissueinstrumentmass analyzernext generationnoveloperationresearch studyultra high pressure
中文摘要
描述(由申请人提供):在本申请中,我们正在申请购买ThermoScience下一代Q-LTQ轨道探测器的资金。我们之所以需要这台仪器,是因为它的功能非常适合自下而上、中间向下和自上而下的蛋白质表征、有限样本的高灵敏度定量蛋白质组学和翻译后修饰分析。所需的新一代混合Orbitrap比目前的LTQ Orbitrap Elite有几个关键改进,使其能够实现更好的性能:1)质量选择四极杆可用于选择用于Orbitrap或离子陷阱分析的离子,2)离子陷阱和Orbitrap质谱仪并行操作,可显著提高扫描速度,3)HCD单元,用于在单离子或多路模式下离子积累,4)在MSN分析的任何阶段均可完全灵活地进行CID、HCD和ETD解离,5)具有先进的瞬时处理的超高场Orbitrap,6)新颖的高性能前端ETD源和专用的内部质量校准。这些改进加上开销的降低,在不牺牲灵敏度或动态范围的情况下,实现了比其他设计更高的高分辨率数据采集速率。所请求的下一代Orbitrap的更快的MS1和MS2组合扫描速率对于高效超高压LC分离的LC-MS/MS至关重要,从而在不损失数据质量的情况下减少蛋白质组实验时间。这一要求的下一代Q-LTQ Orbitrap将对支持几个主要用户的需求至关重要,这些用户在样本有限且灵敏度和吞吐量是关键要求的人体组织上执行大规模蛋白质组学。
英文摘要
DESCRIPTION (provided by applicant): In this application we are requesting funds for the purchase of a ThermoScientific a next-generation Q-LTQ Orbitrap. We are requesting this instrument because its capabilities are well suited for bottom-up, middle-down and top-down protein characterization, high-sensitivity quantitative proteomics of limited samples and post- translational modification analysis. The requested next-generation hybrid Orbitrap has several key improvements over the current LTQ Orbitrap Elite that allow it to achieve better performance: 1) Mass selecting quadrupole available to select ions for Orbitrap or ion trap analysis, 2) Parallel operation of both ion trap and Orbitrap mass analyzers allowing for significantly increased scan rate, 3) HCD cell for ion accumulation in single ion or multiplexed modes, 4) Full flexibility of CID, HCD and ETD dissociations at any stage of MSn analysis, 5) Ultrahigh field Orbitrap with advanced transient processing, 6) Novel, high performance front-end ETD source and dedicated internal mass calibration. These improvements along with reduced overhead result in a high-resolution data acquisition rate greater than other designs without sacrificing sensitivity or dynamic range. The faster combined MS1 and MS2 scan rates of the requested next-gen Orbitrap are essential for LC- MS/MS with high efficiency ultra-high pressure LC separations, resulting in reduced proteomic experiment time without loss of data quality. This requested next-generation Q-LTQ Orbitrap will be critical to support the needs of several Major Users that performing large-scale proteomics on human tissue where samples are limited and sensitivity and throughput are key requirements.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Concurrent renal amyloidosis and thymoma resulting in a fatal ventricular thrombus in a dog.
并发肾淀粉样变性和胸腺瘤导致狗致命的心室血栓。
DOI:
10.1111/jvim.15062
发表时间:
2018
期刊:
Journal of veterinary internal medicine
影响因子:
2.6
作者:
[Loewen,JenniferM, Cianciolo,RachelE, Zhang,Liwen, Yaeger,Michael, Ward,JessicaL, Smith,JodiD, LeVine,DanaN]
通讯作者:
LeVine,DanaN
DOI:
10.1002/pmic.201700442
发表时间:
2018-06
期刊:
Proteomics
影响因子:
3.4
作者:
[Jiang T, Hoover ME, Holt MV, Freitas MA, Marshall AG, Young NL]
通讯作者:
Young NL
DOI:
10.1016/j.mcpro.2022.100256
发表时间:
2022-07
期刊:
MOLECULAR & CELLULAR PROTEOMICS
影响因子:
7
作者:
[Johnson, Benjamin S., Chafin, Lexie, Farkas, Daniela, Adair, Jessica, Elhance, Ajit, Farkas, Laszlo, Bednash, Joseph S., Londino, James D.]
通讯作者:
Londino, James D.
DOI:
10.1016/j.jbc.2021.101327
发表时间:
2021-11
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Ellenbogen JB, Jiang R, Kountz DJ, Zhang L, Krzycki JA]
通讯作者:
Krzycki JA
Demonstration of In Vitro Resurrection of Aged Acetylcholinesterase after Exposure to Organophosphorus Chemical Nerve Agents.
暴露于有机磷化学神经毒剂后老化乙酰胆碱酯酶的体外复活演示。
DOI:
10.1021/acs.jmedchem.7b01620
发表时间:
2018
期刊:
Journal of medicinal chemistry
影响因子:
7.3
作者:
[Zhuang,Qinggeng, Franjesevic,AndrewJ, Corrigan,ThomasS, Coldren,WilliamH, Dicken,Rachel, Sillart,Sydney, DeYong,Ashley, Yoshino,Nathan, Smith,Justin, Fabry,Stephanie, Fitzpatrick,Keegan, Blanton,TravisG, Joseph,Jojo, Yoder,RyanJ, McElro]
通讯作者:
McElro
Identification of Histone Modification Interaction Networks
-
批准号:7570472
-
项目类别:
-
资助金额:$26.25万
-
财政年份:2009
-
负责人:Michael A. Freitas
-
依托单位:
Identification of Histone Modification Interaction Networks
-
批准号:7897917
-
项目类别:
-
资助金额:$26.25万
-
财政年份:2009
-
负责人:Michael A. Freitas
-
依托单位:
Acquisition of a high-throughput high mass accuracy MS for chromatin research
-
批准号:7215080
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2007
-
负责人:Michael A. Freitas
-
依托单位:
Assays for Screening Histone Modification in Cancer
-
批准号:6941103
-
项目类别:
-
资助金额:$23.55万
-
财政年份:2004
-
负责人:Michael A. Freitas
-
依托单位:
Assays for Screening Histone Modification in Cancer
-
批准号:7115333
-
项目类别:
-
资助金额:$22.99万
-
财政年份:2004
-
负责人:Michael A. Freitas
-
依托单位:
Assays for Screening Histone Modification in Cancer
-
批准号:6762146
-
项目类别:
-
资助金额:$23.55万
-
财政年份:2004
-
负责人:Michael A. Freitas
-
依托单位:
Assays for Screening Histone Modifications in Cancer
-
批准号:8069229
-
项目类别:
-
资助金额:$22.67万
-
财政年份:2004
-
负责人:Michael A. Freitas
-
依托单位:
Assays for Screening Histone Modification in Cancer
-
批准号:7256926
-
项目类别:
-
资助金额:$22.33万
-
财政年份:2004
-
负责人:Michael A. Freitas
-
依托单位:
Assays for Screening Histone Modifications in Cancer
-
批准号:8268528
-
项目类别:
-
资助金额:$22.67万
-
财政年份:2004
-
负责人:Michael A. Freitas
-
依托单位:
Assays for Screening Histone Modifications in Cancer
-
批准号:8490699
-
项目类别:
-
资助金额:$21.31万
-
财政年份:2004
-
负责人:Michael A. Freitas
-
依托单位:
Assays for Screening Histone Modifications in Cancer
-
批准号:7898985
-
项目类别:
-
资助金额:$23.38万
-
财政年份:2004
-
负责人:Michael A. Freitas
-
依托单位:
Shared Resource 14: Proteomics (PSR)
-
批准号:10553346
-
项目类别:
-
资助金额:$22.51万
-
财政年份:1997
-
负责人:Michael A. Freitas
-
依托单位:
Shared Resource 14: Proteomics (PSR)
-
批准号:10333303
-
项目类别:
-
资助金额:$22.51万
-
财政年份:1997
-
负责人:Michael A. Freitas
-
依托单位:
Shared Resource 14: Proteomics (PSR)
-
批准号:10090017
-
项目类别:
-
资助金额:$22.51万
-
财政年份:1997
-
负责人:Michael A. Freitas
-
依托单位:
Proteomics Shared Resource
-
批准号:9221258
-
项目类别:
-
资助金额:$13.95万
-
财政年份:--
-
负责人:Michael A. Freitas
-
依托单位:
国内基金
海外基金
登录
查看更多内容
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:肖将尉
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
-
批准号:81903002
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王斐斐
-
依托单位:
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
-
批准号:81402419
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨翠霞
-
依托单位:
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
-
批准号:31271248
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:李伟
-
依托单位:
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
-
批准号:81160050
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:邵立健
-
依托单位: